Key result
Inhibition of Aminopeptidase-A by injection of anti-APA antibodies in 1-day-old mice caused temporary podocyte foot-process effacement, suggesting a minimal role for APA during nephrogenesis.
Why the study?
Does inhibition of Aminopeptidase-A affect nephrogenesis in 1-day-old mice?
Does inhibition of Aminopeptidase-A affect nephrogenesis in 1-day-old mice?
Aminopeptidase-A is expressed in developing podocytes and proximal tubular cells, but its inhibition only causes temporary podocyte foot-process effacement, indicating a minimal role in nephrogenesis.
Aminopeptidase-A (APA) is a metalloprotease that cleaves N-terminal aspartyl and glutamyl residues from peptides. Its best-known substrate is angiotensin II (Ang II), the most active compound of the renin-angiotensin system (RAS). The RAS is involved in renal development. Most components of the RAS system are expressed in the developing kidney. Thus far, APA has not been studied in detail. In the present study we have evaluated the expression of APA at the protein, mRNA, and enzyme activity (EA) level in the kidney during nephrogenesis. Furthermore, we have studied the effect of inhibiting APA EA by injection of anti-APA antibodies into 1-day-old mice. APA expression was observed from the comma stage onwards, predominantly in the developing podocytes and brush borders of proximal tubular cells. Notably, APA was absent in the medulla or the renal arterioles. Inhibition of APA EA caused temporary podocyte foot-process effacement, suggesting a minimum role for APA during nephrogenesis.
No takes yet. Share an insight, caveat, or question.
Dijkman et al. (2005) studied Nephrogenesis. Anti-APA antibodies was evaluated on Podocyte foot-process effacement. Inhibition of Aminopeptidase-A by injection of anti-APA antibodies in 1-day-old mice caused temporary podocyte foot-process effacement, suggesting a minimal role for APA during nephrogenesis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: